CategoriesFiles 3
Cost Partnership Model
Helpful diagrams for understanding the theory and mechanism of PCUT's Cost Partnership Model 5
Mecasermine Rinfabate Human Studies
At least 129 human patients have taken Mecasermine Rinfabate while participating in controlled clinical trials.� Countless have used the product through GHIS prescription, off-label prescription, and investigational new drug (IND) compassionate use authorization. No Serious Adverse Events (SAE)'s have been attributed to the intervention. The peer reviewed reports of five of the five clinical trials are here. 5
Scientific Premise
Product formulations and merit for clinical development in rare, life-threatening disorders like ALS.
|
